Shennon Biotechnologies

Shennon Biotechnologies

生物技术研究

San Francisco,California 2,196 位关注者

Analyze, understand & manipulate immune cells on the single cell level to develop better treatments for human diseases

关于我们

ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy. We utilize the platform to functionally profile immune cells and their cognate antigens and apply this knowledge to develop more effective therapies against solid tumors and autoimmune diseases. Based in San Francisco next to UCSF Mission Bay, we are funded by DCVC, Foundation Capital and AV8. www.shennonbio.com

网站
https://www.shennonbio.com
所属行业
生物技术研究
规模
11-50 人
总部
San Francisco,California
类型
私人持股
创立
2021
领域
Single cell functional profiling、Immunotherapy target discovery、Ultra high throughput analysis、More effective Immunotherapy和Curative treatments for solid tumors

地点

  • 主要

    2325 3rd Street

    US,California,San Francisco,94107

    获取路线

Shennon Biotechnologies员工

动态

相似主页

融资